Related Experiment Video
Updated: Dec 24, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Genomics and precision surgery for head and neck squamous cell carcinoma
Antoine Galmiche1, Zuzana Saidak2, Jebrane Bouaoud3
1EA7516 « CHIMERE », Université de Picardie Jules Verne, Amiens, France; Department of Biochemistry, Centre de Biologie Humaine, CHU, Amiens, France.
Genomic analysis can personalize head and neck squamous cell carcinoma (HNSCC) surgery. Understanding tumor biology improves surgical indications, procedures, and patient follow-up for better outcomes.
Area of Science:
- Oncology
- Genomics
- Surgical Oncology
Background:
- Tumor biology significantly influences treatment response and patient outcomes.
- Genomic insights offer potential for refining cancer therapies and patient stratification.
- Head and neck squamous cell carcinoma (HNSCC) presents complex challenges in surgical management.
Purpose of the Study:
- To explore the application of genomics in enhancing the surgical treatment of HNSCC.
- To examine how genomic analyses can guide surgical indications, procedure selection, and patient follow-up.
- To highlight the role of tumor biology in surgical outcomes for HNSCC patients.
Main Methods:
- Review of studies investigating the impact of genomics on surgical outcomes in HNSCC.
- Analysis of genomic data for refining diagnosis, staging, and treatment planning.
- Discussion of emerging genomic technologies and their influence on surgical practice.
Main Results:
- Genomic analyses can improve pathological diagnosis and staging of HNSCC.
- Tumor biology, elucidated through genomics, is crucial for predicting surgical outcomes.
- Genomic biomarkers facilitate a personalized approach to HNSCC surgery.
Conclusions:
- Genomics provides practical tools to optimize surgical treatment for HNSCC.
- Identification of genomic biomarkers supports the development of precision surgery for HNSCC.
- Personalizing surgical practice based on tumor biology is the future of HNSCC management.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...